Sweden's SciBase Q4 sales rise on US, skin barrier growth

Reuters03-13

Sweden's SciBase Q4 sales rise on US, skin barrier growth

Overview

Sweden medical technology firm's Q4 net sales rose 45% yr/yr, loss after tax widened
Gross margin fell to 63% from 68.5%, impacted by currency and higher input costs

Outlook

Company did not provide specific financial or operational guidance for the future in its press release

Result Drivers

ELECTRODE SALES - Electrode sales volume rose 67% in Q4, with repeat sales to existing customers up 48%
GROSS MARGIN PRESSURE - Gross margin was negatively affected by currency, higher gold prices, initial delivery to Castle Biosciences, and increased production investments
US AND SKIN BARRIER GROWTH - US skin cancer sales rose 84% (106% in local currency), and skin barrier segment sales surged 294%

Company press release: ID:nWkr5bvdrp

Key Details

Metric	Beat/Miss	Actual	Consensus Estimate
Q4 Sales		SEK 12.48 mln
Q4 EPS		-SEK 0.06
Q4 Net Income		-SEK 25.30 mln
Q4 Gross Margin		63.00%

Analyst Coverage

Wall Street's median 12-month price target for SciBase Holding AB (publ) is SEK0.50, about 79.9% above its March 12 closing price of SEK0.28

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2619166003?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-13 15:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2619166003","market":"nz","top_or_hot":-1,"title":"Sweden's SciBase Q4 sales rise on US, skin barrier growth","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Sweden's SciBase Q4 sales rise on US, skin barrier growth</title></head><body><p><span>Overview</span></p><ul><li><p>Sweden medical technology firm's Q4 net sales rose 45% yr/yr, loss after tax widened</p></li><li><p>Gross margin fell to 63% from 68.5%, impacted by currency and higher input costs</p></li></ul><p><span>Outlook</span></p><ul><li><p>Company did not provide specific financial or operational guidance for the future in its press release</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>ELECTRODE SALES - Electrode sales volume rose 67% in Q4, with repeat sales to existing customers up 48%</p></li><li><p>GROSS MARGIN PRESSURE - Gross margin was negatively affected by currency, higher gold prices, initial delivery to <a href=\"https://laohu8.com/S/CSTL\">Castle Biosciences</a>, and increased production investments</p></li><li><p>US AND SKIN BARRIER GROWTH - US skin cancer sales rose 84% (106% in local currency), and skin barrier segment sales surged 294%</p></li></ul><p>Company press release: <span>ID:nWkr5bvdrp</span></p><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>Q4 Sales</p></td><td></td><td><p>SEK 12.48 mln</p></td><td></td></tr><tr><td><p>Q4 EPS</p></td><td></td><td><p>-SEK 0.06</p></td><td></td></tr><tr><td><p>Q4 Net Income</p></td><td></td><td><p>-SEK 25.30 mln</p></td><td></td></tr><tr><td><p>Q4 Gross Margin</p></td><td></td><td><p>63.00%</p></td><td></td></tr></tbody></table><p><span>Analyst Coverage</span></p><ul><li><p>Wall Street's median 12-month price target for SciBase Holding AB (publ) is SEK0.50, about 79.9% above its March 12 closing price of SEK0.28</p></li></ul><p>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.</p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sweden's SciBase Q4 sales rise on US, skin barrier growth</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSweden's SciBase Q4 sales rise on US, skin barrier growth\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-13 15:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Sweden's SciBase Q4 sales rise on US, skin barrier growth</title></head><body><p><span>Overview</span></p><ul><li><p>Sweden medical technology firm's Q4 net sales rose 45% yr/yr, loss after tax widened</p></li><li><p>Gross margin fell to 63% from 68.5%, impacted by currency and higher input costs</p></li></ul><p><span>Outlook</span></p><ul><li><p>Company did not provide specific financial or operational guidance for the future in its press release</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>ELECTRODE SALES - Electrode sales volume rose 67% in Q4, with repeat sales to existing customers up 48%</p></li><li><p>GROSS MARGIN PRESSURE - Gross margin was negatively affected by currency, higher gold prices, initial delivery to <a href=\"https://laohu8.com/S/CSTL\">Castle Biosciences</a>, and increased production investments</p></li><li><p>US AND SKIN BARRIER GROWTH - US skin cancer sales rose 84% (106% in local currency), and skin barrier segment sales surged 294%</p></li></ul><p>Company press release: <span>ID:nWkr5bvdrp</span></p><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>Q4 Sales</p></td><td></td><td><p>SEK 12.48 mln</p></td><td></td></tr><tr><td><p>Q4 EPS</p></td><td></td><td><p>-SEK 0.06</p></td><td></td></tr><tr><td><p>Q4 Net Income</p></td><td></td><td><p>-SEK 25.30 mln</p></td><td></td></tr><tr><td><p>Q4 Gross Margin</p></td><td></td><td><p>63.00%</p></td><td></td></tr></tbody></table><p><span>Analyst Coverage</span></p><ul><li><p>Wall Street's median 12-month price target for SciBase Holding AB (publ) is SEK0.50, about 79.9% above its March 12 closing price of SEK0.28</p></li></ul><p>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.</p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nL1N40108S:1","article_id":"2619166003","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2619166003","pubTimestamp":1773386015,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Sweden's SciBase Q4 sales rise on US, skin barrier growthOverviewSweden medical technology firm's Q4 net sales rose 45% yr/yr, loss after tax widenedGross margin fell to 63% from 68.5%, impacted by cu","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","CSTL":"Castle Biosciences, Inc.","LU0203347892.USD":"SCHRODER ISF QEP GLOBAL ACTIVE VALLUE \"A\" (USD)  INC AV","LU0203345920.USD":"SCHRODER ISF QEP GLB ACT. VL \"A\" (USD) ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4149":"建筑机械与重型卡车","CMI":"康明斯","LU0154245756.USD":"BNP PARIBAS US MID CAP \"C\" (USD) ACC","BK4585":"ETF&股票定投概念","BK4196":"保健护理服务","BK4567":"ESG概念","LU0154245673.USD":"BNP PARIBAS US MID CAP \"C\" (USD) INC"},"translate_title":"瑞典SciBase第四季度销售额因美国和皮肤屏障增长而增长","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CMI":0.9,"CSTL":0.9},"content_text":"Sweden's SciBase Q4 sales rise on US, skin barrier growthOverviewSweden medical technology firm's Q4 net sales rose 45% yr/yr, loss after tax widenedGross margin fell to 63% from 68.5%, impacted by currency and higher input costsOutlookCompany did not provide specific financial or operational guidance for the future in its press releaseResult DriversELECTRODE SALES - Electrode sales volume rose 67% in Q4, with repeat sales to existing customers up 48%GROSS MARGIN PRESSURE - Gross margin was negatively affected by currency, higher gold prices, initial delivery to Castle Biosciences, and increased production investmentsUS AND SKIN BARRIER GROWTH - US skin cancer sales rose 84% (106% in local currency), and skin barrier segment sales surged 294%Company press release: ID:nWkr5bvdrpKey DetailsMetricBeat/MissActualConsensus EstimateQ4 SalesSEK 12.48 mlnQ4 EPS-SEK 0.06Q4 Net Income-SEK 25.30 mlnQ4 Gross Margin63.00%Analyst CoverageWall Street's median 12-month price target for SciBase Holding AB (publ) is SEK0.50, about 79.9% above its March 12 closing price of SEK0.28For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2619166003","isCrawlerRequest":true}